Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Bain Capital exits Emcure Pharma after selling remaining stake, ends 12-year bet
Shares of Emcure Pharmaceuticals Ltd ended at ₹1,881.90, up by ₹43.75, or 2.38%, on the BSE.
Stocks to buy or sell: Osho Krishan of Angel One suggests buying HDFC Bank, Emcure Pharma shares on 25 June - Mint
Stocks to buy or sell: Osho Krishan of Angel One suggests buying HDFC Bank, Emcure Pharma shares on 25 JuneMint
Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, Vedanta
Indian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but uncertainty persists due to mixed heavyweight stock trends. Investors are advised to focus on stock-specific opportunities as analysts maintain a cautious outlook.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
Block deals: Four stocks see large trades worth over ₹2,000 crore on Tuesday; Check how they reacted
Barring Bluestone Jewellery, whose shares are trading with losses of over 5%, shares of Ajanta Pharma, Emcure Pharma, and Capital Small Finance Bank are trading with gains between 1% to 4% after their respective block deals on Tuesday.
Emcure Pharma receives 7 US FDA observations for Sanand formulations facility in Gujarat
On Friday (May 15), shares of Emcure Pharmaceuticals Ltd ended at ₹1,702.30, up by ₹28.90, or 1.73%, on the BSE.
Stocks to Watch today: Hero MotoCorp, Paytm, L&T, Bajaj Auto, Policybazaar
Stocks to Watch today, Wednesday, May 6, 2026: Vedanta, Zen Tech, Grasim Industries, PNB, and Emcure Pharma are among the top stocks to watch today
Emcure eyes India growth, global deals amid strong demand
Emcure Pharmaceuticals is boosting domestic expansion, R&D, and manufacturing. The company is also exploring acquisition opportunities in India and internationally. New products are expected to drive significant growth. Emcure's partnership with Novo Nordisk for GLP-1 therapies and a pipeline of complex injectables will support future momentum.
Emcure Pharma Q4 Results: Stock slips from 52-week high despite revenue, margin growth
Emcure Pharma posts 29% profit growth and 17% revenue rise in Q4FY26; stock falls over 5% after hitting a 52-week high of ₹1,830, despite strong international business momentum and margin gains.
Stock Alert: Wockhardt, Jindal Stainless, Petronet LNG, Manappuram Finance, Aarti Industries
Larsen & Toubro, Mahindra and Mahindra, Punjab National Bank, Marico, Hero Motocorp, Lloyds Metals and Energy, SRF, Coforge, United Breweries, Poonawalla Fincorp, Ajanta Pharma, Emcure Pharmaceuticals, Aadhar Housing Finance, Gallantt Ispat, Jammu and Kashmir Bank, Voltamp Transformers, AAVAS Financiers, Lloyds Engineering Works, Alkyl Amines Chemicals, SJS Enterprises, Shilchar Technologies, GNG Electronics, Gujarat Heavy Chemicals, Aeroflex Industries, Shanthi Gears, Shoppers Stop, Dalmia Bharat Sugar and Industries, Cigniti Technologies, Raymond Realty, Raymond, Shipping Corporation of India Land and Assets, PTC India Financial Services, Spandana Sphoorty Financial, Dolphin Offshore Enterprises (India), CFF Fluid Control, DCW, Automobile Corporation of Goa (ACGL), Paushak, Mafatlal Industries, B Right Realestate, Kothari Petrochem, Foseco Crucible (India), Sutlej Textiles and Industries, Primo Chemicals, Onward Technologies, Kriti Nutrients, Jenburkt Pharma, Kriti Industries ..
Q4 Results Today: Coforge, Larsen And Toubro, Raymond, Emcure Pharma, Mahindra And Mahindra Among 60+ Companies To Declare Earnings
United Breweries, Raymond Realty, Shoppers Stop and Punjab National Bank are among the companies slated to declare earnings on May 5.
Mauritius-based entity sells Rs 289 crore worth shares in Emcure Pharmaceuticals via block deal; Norges Bank acquirer
Emcure Pharmaceuticals saw a significant block deal where BC Investments IV Limited sold 18 lakh shares for Rs 289 crore to Norges Bank. The pharma company, which manufactures APIs and formulations, has shown strong performance with a 67% return in the past 12 months and a 50% YoY growth in net profit.